Latest News on Dpco
Showing of 0 - 10 from 6 results
Dpco - Total results - 6
Feb 28, 2019
National Pharmaceutical Pricing Authority brings 42 non-scheduled cancer drugs under price control, caps trade margin at 30%Currently, 57 anti-cancer drugs are under price control as scheduled formulations
Sep 03, 2018
Price control, ad-hoc regulatory changes and new policies may hamper pharma sector growth: PfizerThe Indian pharma market (IPM) stood at Rs 121,833 crore at the end of the financial year 2018, growing at 6.3 percent over the last 12 months period
Dec 22, 2017
NPPA sets deadline to lower prices of syringes and needles; manufacturers volunteer, set trade margin at 75%Syringe and needle manufacturers set trade margins at maximum 75 percent in an attempt to self-regulate prices; NPPA sets deadline to 26 January
Apr 27, 2017
Medical stent regulation row: Govt's move to prohibit companies from withdrawing stents is wrongOver the last few months, the National Pharmaceutical Pricing Authority (NPPA) has been in a tussle with manufacturers of cardiac stents.
Jun 06, 2016
Prices of 56 drugs to come down; NPPA fixes ceiling ratesPrices may come down of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and high blood pressure, with the government fixing their ceiling prices under the drug pricing control mechanism.
Oct 27, 2014
De-controlling drug prices: SC refuses to interfere in Centre's decisionThe Supreme Court today refused to interfere with the Centre's decision to de-control prices of 108 cardiac and diabetes drugs saying the issue can be raised before the competent authority through representation.